Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor

  • J Med Chem. 1996 Apr 26;39(9):1767-70. doi: 10.1021/jm960054c.
D C Dean  1 ,  R P Nargund ,  S S Pong ,  L Y Chaung ,  P Griffin ,  D G Melillo ,  R L Ellsworth ,  L H Van der Ploeg ,  A A Patchett ,  R G Smith
Affiliations
  • 1. Department of Drug Metabolism, Merck Research Laboratories, Merck & Co., Rahway, New Jersey 07065, USA.